Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 5 (2008), Issue 5 (May)

1. Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.
   BMC Cancer, 8: 101. [Abstract] [Full-text]
2. Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.
   Br J Cancer, 98(9): 1500-7. [Abstract] [Full-text]
3. Surgical technique in pedicled thoracodorsal artery perforator flaps: a clinical experience with 99 patients.
   Plast Reconstr Surg, 121(5): 1632-41. [Abstract] [Full-text]
4. EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers.
   Br J Cancer, 98(9): 1536-9. [Abstract] [Full-text]
5. The role of early life genistein exposures in modifying breast cancer risk.
   Br J Cancer, 98(9): 1485-93. [Abstract] [Full-text]
6. Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
   J Natl Cancer Inst, 100(9): 642-8. [Abstract] [Full-text]
7. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
   J Natl Cancer Inst, 100(9): 672-9. [Abstract] [Full-text]
8. Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer.
   Genes Chromosomes Cancer, 47(7): 633-8. [Abstract] [Full-text]
9. HER2-positive early breast cancer and trastuzumab: a surgeon's perspective.
   Ann Surg Oncol, 15(6): 1677-88. [Abstract] [Full-text]
10. Radiofrequency ablation of invasive breast carcinomas: a phase II trial.
    Ann Surg Oncol, 15(6): 1689-95. [Abstract] [Full-text]
11. Timing of surgical intervention for the intact primary in stage IV breast cancer patients.
    Ann Surg Oncol, 15(6): 1696-702. [Abstract] [Full-text]
12. Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed.
    Ann Surg Oncol, 15(6): 1710-6. [Abstract] [Full-text]
13. Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy.
    Ann Surg Oncol, 15(6): 1717-22. [Abstract] [Full-text]
14. Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI?
    Ann Surg Oncol, 15(6): 1703-9. [Abstract] [Full-text]
15. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.
    J Clin Oncol, 26(14): 2358-63. [Abstract] [Full-text]
16. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
    J Clin Oncol, 26(14): 2373-8. [Abstract] [Full-text]
17. Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.
    J Clin Oncol, 26(14): 2364-72. [Abstract] [Full-text]
18. Sebaceous carcinoma of the nipple.
    J Cutan Pathol, 35(6): 608-10. [Abstract] [Full-text]
19. Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Am J Epidemiol, 167(10): 1207-16. [Abstract] [Full-text]
20. A prospective study of multivitamin supplement use and risk of breast cancer.
    Am J Epidemiol, 167(10): 1197-206. [Abstract] [Full-text]
21. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?
    J Am Coll Surg, 206(5): 1045-50; discussion 1050-2. [Abstract] [Full-text]
22. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    J Am Coll Surg, 206(5): 1038-42; discussion 1042-4. [Abstract] [Full-text]
23. Association between radiologists' experience and accuracy in interpreting screening mammograms.
    BMC Health Serv Res, 8: 91. [Abstract] [Full-text]
24. mAtNOS1 induces apoptosis of human mammary adenocarcinoma cells.
    Life Sci, 82(21): 1077-82. [Abstract] [Full-text]
25. SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue.
    Br J Cancer, 98(10): 1641-5. [Abstract] [Full-text]
26. Evaluation of coplanar partial left breast irradiation using tomotherapy-based topotherapy.
    Int J Radiat Oncol Biol Phys, 71(2): 603-10. [Abstract] [Full-text]
27. Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation.
    Int J Radiat Oncol Biol Phys, 71(2): 595-602. [Abstract] [Full-text]
28. Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.
    Int J Radiat Oncol Biol Phys, 71(2): 435-40. [Abstract] [Full-text]
29. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
    JAMA, 299(18): 2151-63. [Abstract] [Full-text]
30. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8.
    Proc Natl Acad Sci U S A, 105(19): 6924-9. [Abstract] [Full-text]
31. Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.
    Mol Cell Biol, 28(11): 3830-49. [Abstract] [Full-text]
32. Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases.
    Cancer Sci, 99(6): 1237-42. [Abstract] [Full-text]
33. Norsolorinic acid from Aspergillus nidulans inhibits the proliferation of human breast adenocarcinoma MCF-7 cells via Fas-mediated pathway.
    Basic Clin Pharmacol Toxicol, 102(6): 491-7. [Abstract] [Full-text]
34. Basal-like breast cancer: a critical review.
    J Clin Oncol, 26(15): 2568-81. [Abstract] [Full-text]
35. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
    J Clin Oncol, 26(15): 2473-81. [Abstract] [Full-text]
36. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
    Radiology, 247(3): 651-7. [Abstract] [Full-text]
37. Mammography before diagnosis among women age 80 years and older with breast cancer.
    J Clin Oncol, 26(15): 2482-8. [Abstract] [Full-text]
38. Sentinel lymph node biopsy in operations for recurrent breast cancer.
    Eur J Surg Oncol, 34(6): 626-30. [Abstract] [Full-text]
39. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
    Eur J Surg Oncol, 34(6): 631-5. [Abstract] [Full-text]
40. Clinical impact of false-negative sentinel lymph nodes in breast cancer.
    Eur J Surg Oncol, 34(6): 620-5. [Abstract] [Full-text]
41. Isotope labelling and axillary node harvesting strategies for breast cancer.
    Eur J Surg Oncol, 34(6): 615-9. [Abstract] [Full-text]
42. MDCT of the breast.
    AJR Am J Roentgenol, 190(6): 1644-51. [Abstract] [Full-text]
43. Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.
    AJR Am J Roentgenol, 190(6): 1630-6. [Abstract] [Full-text]
44. A prospective study of age-specific physical activity and premenopausal breast cancer.
    J Natl Cancer Inst, 100(10): 728-37. [Abstract] [Full-text]
45. Timing of familial breast cancer in sisters.
    J Natl Cancer Inst, 100(10): 721-7. [Abstract] [Full-text]
46. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
    Mol Pharmacol, 73(6): 1761-8. [Abstract] [Full-text]
47. Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes.
    Oncogene, 27(23): 3345-59. [Abstract] [Full-text]
48. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
    Oncogene, 27(23): 3274-81. [Abstract] [Full-text]
49. Full-thickness resection with myocutaneous flap reconstruction for locally recurrent breast cancer.
    Ann Thorac Surg, 85(6): 1894-900. [Abstract] [Full-text]
50. Automatic time-motion study of a multistep preoperative process.
    Anesthesiology, 108(6): 1109-16. [Abstract] [Full-text]
51. Immunohistochemical antibodies in breast cancer HER2 diagnostics. A comparative immunohistochemical and fluorescence in situ hybridization study.
    Tumour Biol, 29(1): 18-27. [Abstract] [Full-text]
52. The fibromatosis signature defines a robust stromal response in breast carcinoma.
    Lab Invest, 88(6): 591-601. [Abstract] [Full-text]
53. Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact?
    J Am Coll Surg, 206(3): 1116-21. [Abstract] [Full-text]
54. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study.
    Am J Epidemiol, 167(11): 1312-20. [Abstract] [Full-text]
55. Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study.
    Br J Cancer, 98(11): 1870-5. [Abstract] [Full-text]
56. Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.
    Br J Cancer, 98(11): 1753-8. [Abstract] [Full-text]
57. Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.
    Br J Cancer, 98(11): 1745-52. [Abstract] [Full-text]
58. Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
    Br J Cancer, 98(11): 1741-4. [Abstract] [Full-text]
59. Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment.
    Br J Cancer, 98(11): 1845-51. [Abstract] [Full-text]
60. Lower breast cancer survival in mothers of children with a malignancy: a national study.
    Br J Cancer, 98(11): 1876-8. [Abstract] [Full-text]
61. Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
    J Clin Oncol, 26(16): 2659-65. [Abstract] [Full-text]
62. Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.
    J Clin Oncol, 26(16): 2636-43. [Abstract] [Full-text]
63. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
    J Clin Oncol, 26(16): 2630-5. [Abstract] [Full-text]
64. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer.
    J Clin Oncol, 26(16): 2621-9. [Abstract] [Full-text]
65. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Nat Genet, 40(6): 741-50. [Abstract] [Full-text]
66. Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.
    J Clin Oncol, 26(16): 2653-8. [Abstract] [Full-text]
67. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.
    Nat Genet, 40(6): 703-6. [Abstract] [Full-text]
68. Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.
    J Clin Oncol, 26(16): 2644-52. [Abstract] [Full-text]
69. Antibody-functionalized nano test tubes target breast cancer cells.
    Nanomed, 3(3): 283-92. [Abstract] [Full-text]
70. Primary lymphoma of the breast involving both axillae with bilateral breast carcinoma.
    World J Surg Oncol, 6: 52. [Abstract] [Full-text]
71. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study.
    Lancet Oncol, 9(6): 523-32. [Abstract] [Full-text]
72. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.
    Cancer Sci, 99(7): 1326-33. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.